Deuterium isotope effect on the metabolism and toxicity of 1,2-dibromoethane

doi:10.1016/0041-008X(83)90297-1

Toxicology and Applied Pharmacology

Volume 69, Issue 2, 30 June 1983, Pages 170-178

https://doi.org/10.1016/0041-008X(83)90297-1 Get rights and content

Abstract

The metabolism, hepatotoxicity, and hepatic DNA damage of 1,2-dibromoethane (EDB) and tetradeutero-1,2-dibromoethane (d₄EDB) were compared in male Swiss-Webster mice. In vitro studies that measured bromide ion released from the substrate to monitor the rate of metabolism showed that the hepatic microsomal metabolism of EDB was significantly reduced by deuterium substitution, while metabolism by the hepatic glutathione S-transferases was unaffected. Three hours after ip administration of EDB or d₄EDB (50 mg/kg), there was 42% less bromide in the plasma of d₄EDB-treated mice than in the plasm of EDB-treated mice. This difference demonstrates a significant deuterium isotope effect on the metabolism of EDB in vivo. Although the metabolism of d₄EDB was less than that of EDB 3 hr after exposure, the DNA damage caused by both analogs was not significantly different at this time point. At later time points (8, 24, and 72 hr), d₄EDB caused significantly greater DNA damage than EDB. Since the decreased metabolism of d₄EDB was apparently due to a reduced rate of microsomal oxidation, these data support the hypothesis that conjugation with GSH is responsible for the genotoxic effects of EDB.

References (47)

S. Banerjee et al.
Interaction of potential metabolites of the carcinogen ethylene dibromide with protein and DNA in vitro
Biochem. Biophys. Res. Commun.
(1979)
K. Edwards et al.
Studies with alkylating esters-II
Biochem. Pharmacol.
(1970)
M.L. Gargas et al.
Metabolism of inhaled brominated hydrocarbons: Validation of gas uptake results by determination of stable metabolites
Toxicol. Appl. Pharmacol.
(1982)
A.G. Gornall et al.
Determination of serum proteins by means of the biuret reaction
J. Biol. Chem.
(1949)
F.P. Guengerich et al.
In vitro activation of 1,2-dichloroethane by microsomal and cytosolic enzymes
Toxicol. Appl. Pharmacol.
(1980)
J.M. Kissane et al.
The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system
J. Biol. Chem.
(1958)
R.M. Maiorino et al.
Chromatographic resolution of amino acid adducts of aliphatic halides
Chem.-Biol. Interact.
(1982)
C. Mitoma et al.
Effect of deuteration of the O-CH₃ group on the enzymatic demethylation of o-nitroanisole
Biochim. Biophys. Acta
(1967)
E. Nachtomi
Modulation of the mitotic action of ethylene dibromide
Chem. -Biol. Interactions
(1980)
E. Nachtomi et al.
Repair of rat liver DNA in vivo damaged by ethylene dibromide
Biochem. Pharmacol.
(1977)

S. Parodi et al.

A practical procedure for testing DNA damage in vivo proposed for a pre-screening of chemical carcinogens

Mut. Res.

(1978)

L.R. Pohl et al.

Deuterium isotope effect in bioactivation and heptotoxicity of chloroform

Life Sci.

(1978)

L.R. Pohl et al.

Deuterium isotope effect in in vivo bioactivation of chloroform to phosgene

Biochem. Pharmacol.

(1979)

U. Rannug et al.

The mutagenic effect of 1,2-dichloroethane on Salmonella typhimurium I. Activation through conjugation with glutathione in vitro

Chem. Biol. Interact.

(1978)

J. Sedlak et al.

Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissues with Ellman's reagent

Anal. Biochem.

(1968)

B.H. Stock et al.

A comparison of some effects of DMSO and dimethyl sulphone on rat liver microsomal enzymes

Biochem. Pharmacol.

(1971)

P.J. Van Bladeren et al.

The role of glutathione conjugation in the mutagenicity of 1,2-dibromoethane

Biochem. Pharmacol.

(1980)

P.J. Van Bladeren et al.

The metabolic formation of N-acetyl-S-2-hydroxyethyl-l-cysteine from tetradeutero-1,2-dibromoethane

Biochem. Pharmacol.

(1981)

P.J. Van Bladeren et al.

The influence of disulfiram and other inhibitors of oxidative metabolism on the formation of 2-hydroxyethyl-mercapturic acid from 1,2-dibromoethane by the rat

Biochem. Pharmacol.

(1981)

M. Younes et al.

Glutathione S-transferase activities in rat liver: Effect of some factors influencing the metabolism of xenobiotics

Pharmacol. Res. Commun.

(1980)

S. Banerjee et al.

Binding of carcinogenic halogenated hydrocarbons to cell macromolecules

J. Nat. Cancer Inst.

(1979)

D. Dagani et al.

Deuterium isotope effect in the microsomal metabolism of dimethylnitrosamine

J. Natl. Cancer Inst.

(1976)

B.M. Elliott et al.

Ethylene dibromide and disulfiram: Studies in vivo and in vitro on the mechanism of the observed synergistic carcinogen response

Carcinogenesis

(1980)

Cited by (43)

Deuterated driven new chemical entities: An optimistic way to improve therapeutic efficacy
2023, Bioorganic Chemistry
In organic chemistry, the use of deuterium exchange as a tool to study the mechanism of chemical reaction has been well explored. Since two decades, the research focus on deuterated bioactive molecules has been gaining attention for investigating the therapeutic potential of deuterium replacement in a chemical structure. Recently, Food Drug Administration (FDA) approved the first deuterium-labeled drug “deutetrabenazine”, and notified the deuterated drugs as new chemical entities (NCEs). Henceforth, the deuterium substitution driven structure activity relationship, preclinical pharmacokinetics, and toxicity studies were much initiated. Deuteration of a bioactive molecule often results in improved therapeutic efficacy due to the altered pharmacokinetic profile. This review provides a conceptual framework on the importance of deuterium atom in chemical structure of a drug, and its biological value in improved physiochemical properties, pharmacokinetics, biological target interaction, diagnosis, and toxicity. In addition, this review concisely updated the recent deuteration methods, chemical stability, challenges in drug development, deuterium-based imaging in diagnosis, and selected synthetic scheme of deuterated molecules.
Kinetic Deuterium Isotope Effects in Cytochrome P450 Reactions
2017, Methods in Enzymology
Citation Excerpt :
However, its genotoxicity is related to another pathway, glutathione conjugation (Guengerich, 2005). Deuteration of ethylene dibromide blocks oxidation and increases the genotoxicity in rats (White, Gandolfi, Bowden, & Sipes, 1983), as does administration of the P450 2E1/2A6 inhibitor disulfiram (Wong, Winston, Hong, & Plotnick, 1982). The first application of KIEs to P450 drug metabolism was that of Elison et al. (1961) on the N-demethylation of morphine, which is recognized today as a cytochrome P450 reaction.
Cytochrome P450 (P450, CYP) research provides many opportunities for the application of kinetic isotope effect (KIE) strategies. P450s collectively catalyze oxidations of more substrates than any other group of enzymes, and CH bond cleavage is a major feature in a large fraction of these reactions. The presence of a significant primary deuterium KIE is evidence that hydrogen abstraction is at least partially rate-limiting in the reactions, and this appears to be the case in many P450 reactions. The first report of a KIE in (P450-linked) drug metabolism appeared in 1961 (for morphine N-demethylation), and in a number of cases, it has been possible to modulate the in vivo metabolism or toxicity of chemicals by deuterium substitution. A number of efforts are in progress to utilize deuterium substitution to alter the metabolism of drugs in an advantageous manner.
The species-dependent metabolism of Efavirenz produces a nephrotoxic glutathione conjugate in rats
2000, Toxicology and Applied Pharmacology
Efavirenz, a potent nonnucleoside reverse transcriptase inhibitor widely prescribed for the treatment of HIV infection, produces renal tubular epithelial cell necrosis in rats but not in cynomolgus monkeys or humans. This species selectivity in nephrotoxicity could result from differences in the production or processing of reactive metabolites, or both. A detailed comparison of the metabolites produced by rats, monkeys, and humans revealed that rats produce a unique glutathione adduct. The mechanism of formation and role of this glutathione adduct in the renal toxicity were investigated using both chemical and biochemical probes. Efavirenz was labeled at the methine position on the cyclopropyl ring with the stable isotope deuterium, effectively reducing the formation of the cyclopropanol metabolite, an obligate precursor to the glutathione adduct. This substitution markedly reduced both the incidence and severity of nephrotoxicity as measured histologically. Further processing of this glutathione adduct was also important in producing the lesion and was demonstrated by inhibiting γ-glutamyltranspeptidase with acivicin pretreatment (10 mg/kg, IV) prior to dosing with efavirenz. Again, both the incidence and severity of the nephrotoxicity were reduced, such that four of nine rats given acivicin were without detectable lesions. These studies provide compelling evidence that a species-specific formation of glutathione conjugate(s) from efavirenz is involved in producing nephrotoxicity in rats. Mechanisms are proposed for the formation of reactive metabolites that could be responsible for the renal toxicity observed in rats.
Effects of deuterium labeling on azido amino acid mutagenicity in Salmonella typhimurium
1994, Mutation Research Regular Papers
The mutagenic effects of azide (N₃⁻) anion in bacterial test systems require the formation of the novel mutagenic metabolite, 3-azido-L-alanine (AZAL). Although the mechanism of AZAL-induced mutagenicity is unknown, subsequent bioactivation of this metabolite appears likely. Earlier studies have shown that other azide-containing amino acids are mutagenic as well. In fact, the mutagenic potency of the synthetic AZAl homologue, l-2-amino-4-azidobutanoic acidobutanoic acid (HomoAZAL), was several timesthat of AZAL. To gain insight into the biochemical processing and mutagenicity of azido amino acids in Salmonella typhimurium, several specifically deuterium-labeled azido amino acids have been prepared and tested for mutagenic potency. In addition, the effect of (aminooxy)acetic acid (AOA) (a potent inhibitor of pyridoxal-dependent processes) on AZAL-induced mutagenesis was examined. The results showed that 2-deuterium substitution of AZAL resulted in a slight increase in mutagenic potency, while AOA treatment resulted in no change in AZAL potency. Taken together these findings did not support the involvement of pyridoxal-dependent processes in AZAL bioactivation. In contrast, deuterium substitution adjacent to the azide group in HomoAZAL and 5-azido-l-norvaline (N₃-Norval) resulted in a large decrease in mutagenic potency when compared to the non-deuterium labeled compounds. These observations are consistent with a bioactivation mechanism involving rate-limiting CH bond cleavage in the formation of the ultimate mutagen. Moreover, this effect of deuterium labeling points to processing of the azide-containing side chain as a key feature in the mutagenic activation mechanism.
Metabolism and Genotoxicity of Dihaloalkanes
1994, Advances in Pharmacology
The most thoroughly studied of the dihaloalkanes is ethylene dibromide. Considerable evidence now exists to support the view that glutathione (GSH) conjugation is critical to mutagenicity and probably tumorigenesis. The major DNA adduct is S-[2-(N⁷-guanyl)ethylglutathione and this adduct is most likely to be responsible for the mutations. Several indirect lines of evidence support this view but direct proof is still not available. Three minor guanyl and adenyl adducts have been shown to be present in DNA as well. The events described for ethylene bromide are probably also generally relevant to ethylene dichloride and any other 1,2-dihaloalkanes. 1,2-Dibromo-3-chloropropane (DBCP) is activated by GSH conjugation involving similar chemical reactions (i.e., episulfonium ion formation) and N⁷-guanyl DNA adducts have been characterized. However, the low levels of these formed in vivo make their relevance unclear at this time. Methylene dihalides react with GSH, forming HCHO, but the relevance of this reaction to the mutagenicity of the compounds and their weak carcinogenicity in mice is still unclear. Recent evidence suggests the reaction of a GSH conjugate with DNA to yield the base-pair mutations.
Molecular mechanisms of dibromoalkane cytotoxicity in isolated rat hepatocytes
1993, Biochemical Pharmacology
The cytotoxicty of dibromoalkanes to isolated hepatocytes was proportional to the dibromoalkane concentration and increasing chain length of the dibromoalkane C₂-C₆). The rapid hepatocyte glutathione (GSH) depletion which occurred upon addition of the dibromoalkanes was also dependent on the concentration and chain length of the dibromoalkane. When added to hepatocytes, dibromoalkanes also caused a loss in protein sulfhydryl groups. After a lag period, lipid peroxidation occurred before the onset of cytotoxicity. Antioxidants or removing the oxygen from the medium markedly delayed dibromoalkane cytotoxicity. Bromoaldehydic metabolites formed by cytochrome P450-dependent mixed-function oxidases were probably responsible for lipid peroxidation as deuterated 1,2-dibromoethane (d4-DBE) induced less lipid peroxidation and was less cytotoxic even though GSH was depleted as rapidly and as effectively. Hepatocytes were also more resistant to dibromoalkanes if cytochrome P450 isoenzymes were inactivated with SKF 525A or methyl pyrazole. Furthermore, hepatocyte susceptibility to dibromoalkanes was increased markedly if aldehyde dehydrogenase was inactivated with disulnram, cyanamide or chloral hydrate. Cytochrome P450-induced hepatocytes isolated from pyrazole-, phenobarbital- or 3-methylcholanthrene-pretreated rats were also more susceptible to dibromoalkanes. These results suggest that dibromoalkane-induced cell lysis is due to lipid peroxidation as well as cytochrome P450-dependent formation of toxic bromoaldehydic metabolites which can bind with cellular macromolecules. Dibromoethane GSH conjugates also contribute to DBE cytotoxicity as depleting hepatocyte GSH beforehand increased hepatocyte resistance to DBE but not other dibromoalkanes.

View all citing articles on Scopus

View full text

Deuterium isotope effect on the metabolism and toxicity of 1,2-dibromoethane

Abstract

Biochem. Biophys. Res. Commun.

Biochem. Pharmacol.

Toxicol. Appl. Pharmacol.

J. Biol. Chem.

Toxicol. Appl. Pharmacol.

J. Biol. Chem.

Chem.-Biol. Interact.

Biochim. Biophys. Acta

Chem. -Biol. Interactions

Biochem. Pharmacol.

Mut. Res.

Life Sci.

Biochem. Pharmacol.

Chem. Biol. Interact.

Anal. Biochem.

Biochem. Pharmacol.

Biochem. Pharmacol.

Biochem. Pharmacol.

Biochem. Pharmacol.

Pharmacol. Res. Commun.

Binding of carcinogenic halogenated hydrocarbons to cell macromolecules

J. Nat. Cancer Inst.

Deuterium isotope effect in the microsomal metabolism of dimethylnitrosamine

J. Natl. Cancer Inst.

Ethylene dibromide and disulfiram: Studies in vivo and in vitro on the mechanism of the observed synergistic carcinogen response

Carcinogenesis